Sehgal, Ratika
Perfilyev, Alexander
Männistö, Ville
Ågren, Jyrki
Nilsson, Emma
Käkelä, Pirjo
Ling, Charlotte
de Mello, Vanessa D.
Pihlajamäki, Jussi
Funding for this research was provided by:
GenomMed Doctoral Programme, co-funded by the Horizon 2020 Framework Programme of the European Union (Marie Skłodowska Curie grant agreement No 740264)
Swedish Research Council, Region Skåne
Novo Nordisk Foundation
The Swedish Diabetes Foundation
Påhlsson Foundation
EXODIAB
EFSD
Swedish Foundation for Strategic Research (Dnr IRC15-0067, Dnr IRC15-0067, Dnr IRC15-0067)
Finnish Medical Foundation
Mary and Georg Ehrnrooth Foundation
Finnish Diabetes Research Foundation
Kuopio University Hospital Project grant (EVO/VTR grants 2005-2021)
Academy of Finland grant (Contract no. 138006)
Finnish Cultural Foundation
Article History
Received: 14 March 2022
Accepted: 19 January 2023
First Online: 11 February 2023
Declarations
:
: Written informed consent was obtained from all participants, and the study protocol was approved by the Ethics Committee of the Northern Savo Hospital District (54/2005, 104/2008, and 27/2010) and was in accordance with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.